Conditions:   Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis
Intervention:   Biological: HUMIRA (adalimumab)
Sponsors:   Abbott;   Veeda Clinical Research, Brussels
Recruiting - verified June 2011